Gestational diabetes is not an autoimmune disease. It is a metabolic condition driven by hormonal changes during pregnancy, not by the immune system attacking the pancreas. This is a meaningful distinction because it affects how the condition develops, how it’s treated, and what it means for your health after delivery.
Why Gestational Diabetes Is Metabolic, Not Autoimmune
In autoimmune diabetes (Type 1), the immune system produces antibodies that destroy the insulin-producing cells in the pancreas. Over time, the pancreas loses its ability to make insulin entirely. Gestational diabetes works through a completely different mechanism.
During pregnancy, the placenta produces hormones that help your baby grow, including estrogen, cortisol, and human placental lactogen. These hormones have an important side effect: they interfere with how your body uses insulin, a state called insulin resistance. Your cells become less responsive to insulin, so glucose stays in the bloodstream instead of being absorbed for energy. Normally, the pancreas compensates by producing extra insulin to overcome this resistance. Gestational diabetes develops when your pancreas can’t keep up with the increased demand. The insulin-producing cells are still intact and functioning. They just can’t produce enough insulin to overcome the hormonal blockade.
This is fundamentally different from what happens in Type 1 diabetes, where the cells themselves are destroyed. In gestational diabetes, the problem is supply versus demand, not immune-mediated destruction.
The Role of Placental Hormones
Human placental lactogen (hPL) is the hormone most directly implicated in pregnancy-related insulin resistance. It rises significantly during the third trimester and plays a dual role: it helps regulate how nutrients reach the fetus while simultaneously reducing the mother’s insulin sensitivity. Estrogen and progesterone contribute as well, but hPL appears to be the primary driver of the metabolic shift.
This explains why gestational diabetes typically develops in the second half of pregnancy, when placental hormone production peaks. It also explains why blood sugar levels usually return to normal after delivery, once the placenta is gone and those hormones drop.
What the Autoantibody Evidence Shows
Researchers have specifically tested whether women with gestational diabetes carry the same immune markers found in Type 1 diabetes. The antibodies most associated with autoimmune diabetes, particularly those targeting a protein called GAD65 and another called IA-2, were not found in women with gestational diabetes. Low levels of other islet-related antibodies do appear in some pregnant women, but these show up at similar rates in women with normal blood sugar, suggesting they aren’t driving the condition.
This is strong evidence against an autoimmune mechanism. If gestational diabetes were autoimmune in nature, you would expect to see the same antibody patterns found in Type 1 diabetes, and they simply aren’t there.
A Small But Important Exception
There is one caveat worth knowing about. In rare cases, autoimmune diabetes (either Type 1 or a slower-progressing form called latent autoimmune diabetes in adults) first shows up during pregnancy. Because these women develop high blood sugar during pregnancy, they’re initially diagnosed with gestational diabetes through routine screening. The autoimmune nature of their condition may only become clear during postpartum follow-up, when their blood sugar doesn’t normalize as expected.
These cases share some features with gestational diabetes, including insulin resistance and adult onset, but they involve antibody-positive autoimmune destruction of insulin-producing cells. They represent a small fraction of women diagnosed with gestational diabetes, not a feature of the condition itself. If your blood sugar remains elevated well after delivery, your doctor may test for these antibodies to determine whether something else is going on.
Risk Factors Point to Metabolism, Not Immunity
The risk factors for gestational diabetes further confirm its metabolic nature. The major ones include being over 35, having a pre-pregnancy BMI in the overweight or obese range, gaining excessive weight during early and mid-pregnancy, having a family history of Type 2 diabetes, a personal history of gestational diabetes in a previous pregnancy, and polycystic ovary syndrome (PCOS). Ethnicity also plays a role, with higher rates in certain populations.
None of these are immune-related risk factors. They all relate to how efficiently your body processes glucose and responds to insulin, which is the hallmark of a metabolic condition. Compare this to Type 1 diabetes, where risk is driven by specific genetic markers tied to immune function and a family history of autoimmune diseases.
How It Connects to Type 2 Diabetes Later
The metabolic nature of gestational diabetes has important implications for your long-term health. Women who have had gestational diabetes are roughly nine times more likely to develop Type 2 diabetes compared to women who maintained normal blood sugar during pregnancy. The rates of Type 2 diabetes after gestational diabetes range widely, from 2 to 70 percent depending on the population studied and how many years of follow-up were included (some studies tracked women for nearly three decades).
This connection makes sense when you understand that gestational diabetes and Type 2 diabetes share the same core problem: insulin resistance that exceeds the pancreas’s ability to compensate. Pregnancy essentially stress-tests your metabolic system. If your body struggles to maintain normal blood sugar under the hormonal load of pregnancy, that same vulnerability can resurface later in life when other factors like aging, weight gain, or reduced physical activity increase insulin resistance again.
This is also why the post-delivery period matters. Blood sugar typically normalizes within weeks of giving birth, but the underlying metabolic tendency doesn’t disappear. Postpartum glucose testing, usually done at six weeks or later, helps confirm that levels have returned to normal and establishes a baseline for future monitoring.
How Gestational Diabetes Is Diagnosed
Screening typically happens between 24 and 28 weeks of pregnancy, when placental hormones are high enough to unmask insulin resistance. The most common approach in the U.S. is a two-step process. First, you drink a sugary solution containing 50 grams of glucose and have your blood drawn one hour later. If your blood sugar is elevated, you return for a longer test: a three-hour oral glucose tolerance test using 100 grams of glucose, with blood draws at fasting, one hour, two hours, and three hours. A diagnosis requires at least two readings above the thresholds (fasting at or above 95 mg/dL, one hour at or above 180, two hour at or above 155, three hour at or above 140).
Some practitioners use a one-step approach with a 75-gram glucose load and a two-hour test, which can screen and diagnose in a single visit but requires fasting beforehand. Neither approach involves any immune testing, because the condition isn’t autoimmune. The diagnosis is based entirely on how well your body handles a glucose load during the hormonal environment of late pregnancy.